companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

AMTEQ LTD

NORTH YORK-Canada

Company Name:
Corporate Name:
AMTEQ LTD
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 220 Duncan Mill Rd,NORTH YORK,ON,Canada 
ZIP Code:
Postal Code:
M3B 
Telephone Number: 4163857777 
Fax Number: 4164492941 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
0 
USA SIC Description:
CAREER & VOCATIONAL COUNSELING 
Number of Employees:
 
Sales Amount:
$500,000 to $1 million 
Credit History:
Credit Report:
Unknown 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
AMULET
AMTRANS TRANSPORT INC
AMTICO FLOORING DIV OF AMERICAN BILTRI
Next company profile:
AMTEK SYSTEMS INC
AMTEK SYSTEMS INC
AMT WHOLESALER










Company News:
  • Immunization, Vaccines and Biologicals - World Health . . .
    Trivalent oral polio vaccine (tOPV) – protects against poliovirus types 1, 2, and 3 - following the "OPV Switch" in April 2016, tOPV is no longer in use Bivalent oral polio vaccine (bOPV) – protects against poliovirus types 1, and 3
  • History of polio vaccination - World Health Organization (WHO)
    The ease of administering the oral vaccine made it the ideal candidate for mass vaccination campaigns Hungary began to use it in December 1959 and Czechoslovakia in early 1960, becoming the first country in the world to eliminate polio
  • Two Polio Vaccines - World Health Organization (WHO)
    Poliomyelitis (polio) is a highly infectious viral disease that largely affects children under 5 years of age The virus is transmitted by person-to-person spread mainly through the faecal-oral route or, less frequently, by a common vehicle (e g contaminated water or food) and multiplies in the intestine, from where it can invade the nervous system and cause paralysis
  • Poliomyelitis - World Health Organization (WHO)
    Polio vaccine, given multiple times, can protect a child for life There are two vaccines available: oral polio vaccine and inactivated polio vaccine Both are effective and safe, and both are used in different combinations worldwide, depending on local epidemiological and programmatic circumstances, to ensure the best possible protection to populations can be provided
  • Poliomyelitis - World Health Organization (WHO)
    Inactivated Polio Vaccine (IPV) The requirements for poliomyelitis vaccine (inactivated) were first formulated in 1959 and revised in 1965 Following several advances in technology in vaccine production, the requirements were further
  • Immunization, Vaccines and Biologicals - World Health . . .
    The Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy WHO Indonesia A child receiving oral polio drops
  • Safety profile of nOPV2 vaccine - World Health Organization . . .
    The novel oral polio vaccine (nOPV2) is currently in the wider use roll-out phase under WHO Emergency Use Listing (EUL) for the control of type 2 circulating vaccine-derived poliovirus (cVDPV2) outbreaks, in line with the Strategic Advisory Group of Experts on Immu nization (SAGE) guidance
  • Circulating vaccine-derived poliovirus type 2 (cVDPV2 . . .
    On 9 May 2025, the International Health Regulations (IHR) National Focal Point (NFP) for Papua New Guinea (PNG) notified WHO of the detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) from stool specimens of two healthy children from Morobe province, Papua New Guinea (PNG) The detection of wild poliovirus (WPV) or vaccine-derived poliovirus (VDPV), including from samples taken
  • Polio vaccines: WHO position paper – March 2016
    This position paper on polio vaccines replaces the 2014 WHO position paper, and summarizes recent developments in the field The recommendations from the 2014 WHO position paper on the use of polio vaccine, in particular on
  • Poliomyelitis (polio) in China - World Health Organization (WHO)
    Poliomyelitis (polio) is a highly infectious viral disease that largely affects children under 5 years of age The virus is transmitted by person-to-person spread mainly through the faecal-oral route or, less frequently, by a common vehicle (e g contaminated water or food) and multiplies in the intestine, from where it can invade the nervous system and cause paralysis




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer